By David Douglas

NEW YORK (Reuters Health) - Men with germline mutations in the BRCA1 and BRCA2 genes are at increased cancer risk and may benefit from wider screening than is currently done, according to Israeli researchers.

The international workshop on CLL updated the prognostic criteria for their consensus guideline to include all of the following EXCEPT mutational status in which gene?
Rebecca Kirch, JD, executive vice president, Healthcare Quality & Value, National Patient Advocate Foundation, explains the value of palliative care in the context of the triple aim.
Will payers push for services to be provided on an outpatient basis, thus placing financial burden upon the patient, or will they allow the oncologist or facility to use their discretion as to where the infusion will take place?
A new study compared medical care cost estimates of different cancer types for patients aged at least 18 years and provided important evidence about the cost of cancer care across the age spectrum.
The National Comprehensive Cancer Network has issued updates to the primary and second-line therapy options for the treatment of Hodgkin lymphoma.
A study presented at the European Lung Cancer Congress investigated the effects of multiple therapies on symptom management in ALK-positive non-small cell lung cancer.
According to a study presented at the SG0 2018 Annual Meeting on Women’s Cancer, how can ovarian cancer health disparities be improved?
Robert M Rifkin, MD, FACP, gave an update on the basics, education, and reimbursement of biosimilars, stating that “this will be a huge year” for the the copycat biologics in the United States.
Debra Patt, MD, MPH, MBA, spoke about the major issues affecting patients with cancer and community practices in the United States.